Early life adversity is a pervasive impediment to healthy brain development and mental health in the long term.
Exposure to early life adversity is distressingly common, with nearly two-thirds of people experiencing at least
one significant adversity event before the age of 18. Despite decades of research documenting the long-term
physical and mental toll these early experiences have on individuals, there continues to be a lack of specificity
in how subtypes or dimensions of child adversity propagate particular patterns of neurodevelopment and mental
health aberrations. In recent years, dimensional approaches have led to field-shaping discoveries whereby shared
features of adversity (e.g., threat, deprivation, unpredictability) can be used to make meaningful, domain-specific
predictions about developmental outcomes. A next step in this line of inquiry is to use a dimensional adversity
approach to probe the biological sequalae that initiate and propel adversity-related neurodevelopmental
cascades. Pubertal development, specifically, has been highlighted as a candidate biological process that is both
sensitive to early adversity and occurs in a uniquely plastic developmental window. Puberty induces a major
influx of pubertal hormones that instigate dramatic changes in structural and functional neural development, as
well as stark physical and psychosocial changes. Even in otherwise healthy developmental contexts,
adolescents are at remarkably increased risk for a wide range of psychopathology. To date, early adversity has
been shown to facilitate adaptations that accelerate or preserve resources related to survival, including shifted
or altered pubertal development. However, how specific dimensions of adversity modulate pubertal development,
particularly with respect to sex hormones (e.g., testosterone, estradiol), continues to be weakly characterized.
Even less is known about links between early adversity, puberty, and neurodevelopment, although initial insights
have indicated the possible mechanistic role puberty plays in propagating neuro-phenotypes that increase risk
for psychiatric symptoms. Our novel preliminary results have highlighted specific effects of adversity subtypes
(e.g., threat exposure) as well as pubertal hormones on brain function and structure, which in some cases
amplified risk for psychopathology in adolescents. In the current study, we will integrate these processes into an
overall framework by leveraging a high-risk sample of youth with highly heterogenous adversity experiences,
enrolled from the Boys Town Youth Care program, to investigate how distinct dimensions of adversity affect
puberty and neurodevelopment. To do so, we will use state-of-the-art adversity, neuroimaging, and pubertal
measures, including gonadal and adrenarcheal hair hormone assays (Aim 1). The proposed study will be
designed to test how adversity affects the pubertal transition and will provide fundamental insights into the
neurobiological dynamics that prime individuals to develop psychopathology (Aim 2). Given that pubertal
development is a paramount event marked by malleability, this project has the potential to yield insights on novel
targets for intervention that could promote healthy neurodevelopmental trajectories following childhood adversity.
No Sub Projects information available for 5P20GM144641-03 5593
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P20GM144641-03 5593
Patents
No Patents information available for 5P20GM144641-03 5593
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P20GM144641-03 5593
Clinical Studies
No Clinical Studies information available for 5P20GM144641-03 5593
News and More
Related News Releases
No news release information available for 5P20GM144641-03 5593
History
No Historical information available for 5P20GM144641-03 5593
Similar Projects
No Similar Projects information available for 5P20GM144641-03 5593